As a member of RAB family, the cancer promoting effects of RAB38 has been verified in pancreatic cancer, since RAB38 was correlated with progression in patients with pancreatic adenocarcinoma. The gene discussed is RAB38; the disease is pancreatic adenocarcinoma.